1. Home
  2. MDGL vs CIFR Comparison

MDGL vs CIFR Comparison

Compare MDGL & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • CIFR
  • Stock Information
  • Founded
  • MDGL 2011
  • CIFR 2021
  • Country
  • MDGL United States
  • CIFR United States
  • Employees
  • MDGL N/A
  • CIFR N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • CIFR Investment Bankers/Brokers/Service
  • Sector
  • MDGL Health Care
  • CIFR Finance
  • Exchange
  • MDGL Nasdaq
  • CIFR Nasdaq
  • Market Cap
  • MDGL 6.1B
  • CIFR 5.6B
  • IPO Year
  • MDGL N/A
  • CIFR N/A
  • Fundamental
  • Price
  • MDGL $427.10
  • CIFR $19.04
  • Analyst Decision
  • MDGL Strong Buy
  • CIFR Strong Buy
  • Analyst Count
  • MDGL 10
  • CIFR 10
  • Target Price
  • MDGL $485.78
  • CIFR $12.61
  • AVG Volume (30 Days)
  • MDGL 294.9K
  • CIFR 55.9M
  • Earning Date
  • MDGL 10-30-2025
  • CIFR 10-30-2025
  • Dividend Yield
  • MDGL N/A
  • CIFR N/A
  • EPS Growth
  • MDGL N/A
  • CIFR N/A
  • EPS
  • MDGL N/A
  • CIFR N/A
  • Revenue
  • MDGL $515,547,000.00
  • CIFR $158,849,000.00
  • Revenue This Year
  • MDGL $394.08
  • CIFR $81.77
  • Revenue Next Year
  • MDGL $61.80
  • CIFR $67.84
  • P/E Ratio
  • MDGL N/A
  • CIFR N/A
  • Revenue Growth
  • MDGL 3421.98
  • CIFR 0.11
  • 52 Week Low
  • MDGL $200.63
  • CIFR $1.86
  • 52 Week High
  • MDGL $463.63
  • CIFR $18.18
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 50.64
  • CIFR 83.13
  • Support Level
  • MDGL $425.60
  • CIFR $14.33
  • Resistance Level
  • MDGL $463.63
  • CIFR $16.12
  • Average True Range (ATR)
  • MDGL 14.91
  • CIFR 1.48
  • MACD
  • MDGL -4.55
  • CIFR 0.44
  • Stochastic Oscillator
  • MDGL 20.84
  • CIFR 90.47

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About CIFR Cipher Mining Inc.

Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.

Share on Social Networks: